This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and public health advocates. The Takeaway The 2024 Lancet Commission report is a call to action for healthcare providers and public health advocates. Michos, MD ; Pamela B.
Circulation, Volume 150, Issue Suppl_1 , Page A4145926-A4145926, November 12, 2024. Thus, we aimed to check the knowledge, perception, diagnosis, and management of indirect and direct salt-related ASCVD risk among healthcare professionals.Methods:The survey, consisting of 17 questions, was developed by the Polish Lipid Association (PoLA).
Getty Images milla1cf Fri, 03/08/2024 - 14:35 March 8, 2024 — Novo Nordisk today announced that the U.S. mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established CVD and without diabetes. 2 Wegovy 2.4 1,2 The primary composite outcome occurred in 6.5% with placebo. mg and 36.4%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2024 
52 
Let's personalize your content